Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm with neuroendocrine differentiation that arises from the rectum. It includes well differentiated neuroendocrine tumors (low and intermediate grade) and poorly differentiated neuroendocrine carcinomas (high grade).
Biomarker and diagnostic research for rectum neuroendocrine neoplasm has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
114 publications have been identified in PubMed for rectum neuroendocrine neoplasm. Research spans Case Report / Case Series (28%), Epidemiology / Natural History (22%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 32 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:53 PM UTC
Genetic and Rare Diseases Info Center
Disease patterns and progression | 25 | 22% |
Research summaries | 17 | 15% |
Clinical study results | 17 | 15% |
Testing and diagnosis research | 11 | 10% |
Laboratory research | 6 | 5% |
Other research | 4 | 4% |
New treatment approaches | 2 | 2% |
Nakatani S (2026). [PMID: 40909210](https://pubmed.ncbi.nlm.nih.gov/40909210/). *DEN Open*. [Clinical Trial Publication]
Akiba S (2026). [PMID: 41967953](https://pubmed.ncbi.nlm.nih.gov/41967953/). *Nihon Shokakibyo Gakkai Zasshi*. [Case Report / Case Series]
Shaik R (2026). [PMID: 41798570](https://pubmed.ncbi.nlm.nih.gov/41798570/). *Cureus*. [Review / Meta-Analysis]
Belev B (2026). [PMID: 41812599](https://pubmed.ncbi.nlm.nih.gov/41812599/). *Surg Oncol*. [Diagnostic / Biomarker]
Kassardjian A (2026). [PMID: 41724494](https://pubmed.ncbi.nlm.nih.gov/41724494/). *International journal of surgical pathology*. [Basic Science / Preclinical]
Kobayashi N (2026). [PMID: 41678086](https://pubmed.ncbi.nlm.nih.gov/41678086/). *Ann Nucl Med*. [Clinical Trial Publication]
Sheng YH (2026). [PMID: 41693974](https://pubmed.ncbi.nlm.nih.gov/41693974/). *World journal of gastroenterology*. [Review / Meta-Analysis]
Paramythiotis D (2026). [PMID: 42166089](https://pubmed.ncbi.nlm.nih.gov/42166089/). *J Gastrointest Cancer*. [Review / Meta-Analysis]
Liang YS (2026). [PMID: 41667374](https://pubmed.ncbi.nlm.nih.gov/41667374/). *J Formos Med Assoc*. [Diagnostic / Biomarker]
Fukui Y (2026). [PMID: 41733126](https://pubmed.ncbi.nlm.nih.gov/41733126/). *Dis Colon Rectum*. [Clinical Trial Publication]